Why the study?
Does the combination of verapamil and disopyramide alter the induction of circus movement tachycardia in patients with pre-excitation?
Does the combination of verapamil and disopyramide alter the induction of circus movement tachycardia in patients with pre-excitation?
Disopyramide may reverse the AV-nodal blocking effects of verapamil due to its anticholinergic action, potentially re-enabling circus movement tachycardia in patients with pre-excitation.
Answers are grounded in this paper and cite their sources.
Warrants caution with verapamil-disopyramide combination in pre-excitation; leaves open confirmation of tachycardia re-induction risk.
By means of intracardiac recordings and programmed electrical stimulation of the heart, the combination effect of verapamil and disopyramide on induction of circus movement tachycardia was studied in 8 patients with anomalous extranodal atrioventricular (A-V) pathway. In 4 of 6 patients who manifested reproducible circus movement tachycardia, verapamil, 0.2 mg/kg intravenously administered, prevented the induction of tachycardia by increasing the A-V nodal refractoriness. Disopyramide in a dose of 2 mg/kg was injected 30 minutes after the start of verapamil administration, when prolongation of the A-V nodal conduction time (A-H interval) had continued in most of the patients. Disopyramide lengthened the effective refractory period of the anomalous pathway in all patients in whom this could be determined. The A-H interval, which had been prolonged by verapamil, was shortened in 4 patients and about unchanged in the remaining 4. After addition of disopyramide, sustained tachycardia could be induced in 2 patients who had lost the ability of initiating circus movement tachycardia after verapamil administration. Thus, disopyramide, when administered together with verapamil, may block the effect of verapamil on the A-V node by its anticholinergic action. A concomitant prescription of disopyramide with verapamil in expectation of the depression of both the anomalous pathway and the A-V node may have an untoward outcome.
No takes yet. Share an insight, caveat, or question.
Matsuda et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: